Amrize Ltd $AMRZ Shares Purchased by Gamco Investors INC. ET AL

Gamco Investors INC. ET AL boosted its stake in shares of Amrize Ltd (NYSE:AMRZFree Report) by 108.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 83,999 shares of the company’s stock after buying an additional 43,615 shares during the quarter. Gamco Investors INC. ET AL’s holdings in Amrize were worth $4,076,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in AMRZ. Public Sector Pension Investment Board increased its stake in Amrize by 8.8% in the 3rd quarter. Public Sector Pension Investment Board now owns 306,957 shares of the company’s stock valued at $14,811,000 after purchasing an additional 24,738 shares in the last quarter. Norges Bank purchased a new stake in Amrize during the second quarter worth $670,915,000. Vanguard Group Inc. purchased a new stake in Amrize during the second quarter worth $1,065,029,000. Prudential PLC acquired a new stake in Amrize in the second quarter valued at $754,000. Finally, 111 Capital acquired a new stake in Amrize in the third quarter valued at $996,000.

Insider Buying and Selling

In other news, CFO Ian A. Johnston acquired 1,200 shares of Amrize stock in a transaction that occurred on Thursday, February 19th. The shares were acquired at an average price of $63.92 per share, with a total value of $76,704.00. Following the completion of the purchase, the chief financial officer owned 18,544 shares of the company’s stock, valued at approximately $1,185,332.48. This represents a 6.92% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Jan Philipp Jenisch acquired 60,000 shares of Amrize stock in a transaction that occurred on Friday, March 6th. The shares were purchased at an average cost of $58.05 per share, for a total transaction of $3,483,000.00. Following the purchase, the chief executive officer directly owned 1,703,582 shares of the company’s stock, valued at approximately $98,892,935.10. This trade represents a 3.65% increase in their position. The SEC filing for this purchase provides additional information.

Amrize Trading Up 1.6%

Amrize stock opened at $59.03 on Tuesday. The stock has a 50-day moving average price of $57.71 and a 200 day moving average price of $53.53. Amrize Ltd has a 52 week low of $44.12 and a 52 week high of $65.94. The stock has a market cap of $32.65 billion and a PE ratio of 24.00. The company has a current ratio of 1.64, a quick ratio of 1.10 and a debt-to-equity ratio of 0.37.

Amrize (NYSE:AMRZGet Free Report) last released its earnings results on Tuesday, February 17th. The company reported $0.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.59 by $0.03. The firm had revenue of $2.84 billion during the quarter, compared to analysts’ expectations of $2.95 billion. The business’s revenue for the quarter was down .4% on a year-over-year basis.

Analyst Upgrades and Downgrades

AMRZ has been the subject of several research reports. UBS Group lifted their price target on Amrize from $53.00 to $57.00 and gave the stock a “neutral” rating in a research note on Thursday, January 8th. Sanford C. Bernstein reissued an “outperform” rating and issued a $70.00 price objective on shares of Amrize in a research note on Thursday, December 18th. Royal Bank Of Canada raised their target price on shares of Amrize from $60.00 to $61.00 and gave the company a “sector perform” rating in a report on Thursday, February 19th. Oppenheimer restated an “outperform” rating and set a $70.00 target price (up from $64.00) on shares of Amrize in a research report on Thursday, February 19th. Finally, Stephens began coverage on shares of Amrize in a report on Friday, November 14th. They issued an “overweight” rating and a $60.00 price target on the stock. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat.com, Amrize currently has an average rating of “Moderate Buy” and an average target price of $64.14.

Read Our Latest Analysis on AMRZ

Amrize Profile

(Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Featured Stories

Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZFree Report).

Institutional Ownership by Quarter for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.